Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
PMID: 16595781
doi:10.1093/jnci/djj101
Conclusions: Low levels of vitamin D may be associated with increased cancer incidence and mortality in men, particularly for digestive-system cancers. The vitamin D supplementation necessary to achieve a 25(OH)D increment of 25 nmol/L may be at least 1500 IU/day.
Prospective study of serum vitamin D and cancer mortality in the United States.
Freedman DM, Looker AC, Chang SC, Graubard BI.
J Natl Cancer Inst. 2007 Nov 7;99(21):1594-602. Epub 2007 Oct 30.
PMID: 17971526
doi:10.1093/jnci/djm204
CONCLUSIONS: Our results do not support an association between 25(OH)D and total cancer mortality, although there was an inverse relationship between 25(OH)D levels and colorectal cancer mortality.
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team.
J Natl Cancer Inst. 2008 Jun 4;100(11):796-804. Epub 2008 May 27.
PMID: 18505967
doi:10.1093/jnci/djn152
CONCLUSION: The findings of this large prospective study do not support the hypothesis that vitamin D is associated with decreased risk of prostate cancer; indeed, higher circulating 25(OH)D concentrations may be associated with increased risk of aggressive disease.
In summary, results from this large prospective study of men who underwent standardized prostate cancer screening in the context of a screening trial do not support the hypothesis that higher serum vitamin D status is associated with decreased risk of prostate cancer. The study showed no association of vitamin D level with nonaggressive disease; however, it raises the possibility that higher vitamin D level may be associated with increased risks for aggressive disease, although a clear monotonic dose-response relationship was lacking. Along with recent reports of adverse associations for higher vitamin D status and risk of pancreatic (32) and esophageal (33,34) cancer, caution should be taken in recommending high doses of vitamin D or sunlight exposure to the general public for prostate cancer prevention. Future analyses are warranted to confirm these results and to further clarify the effects of vitamin D on aggressive prostate cancer.
You-Lin Qiao, Sanford M. Dawsey, Farin Kamangar, Jin-Hu Fan, Christian C. Abnet, Xiu-Di Sun, Laura Lee Johnson, Mitchell H. Gail, Zhi-Wei Dong, Binbing Yu, Steven D. Mark, and Philip R. Taylor.
Total and Cancer Mortality After Supplementation With Vitamins and Minerals: Follow-up of the Linxian General Population Nutrition Intervention Trial.
Journal of the National Cancer Institute, 2009 March 24;
DOI: 10.1093/jnci/djp037
Calcium plus vitamin D supplementation and the risk of breast cancer.
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; Women's Health Initiative Investigators.
J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91. Epub 2008 Nov 11.
PMID: 19001601
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.
J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.
PMID: 17623801
Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98:1767-76.
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
PMID: 16595781 [PubMed - indexed fo
Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids.
Bégin ME, Ells G, Das UN, Horrobin DF.
J Natl Cancer Inst. 1986 Nov;77(5):1053-62.
PMID: 3464797